Testing D-OCT Scans for Detecting and Sorting Skin Cancer
Part of Cancer clinical trials.
This study tests a special camera (D-OCT) that takes detailed pictures of suspicious skin spots to see if it can help doctors identify and classify a common skin cancer called basal cell carcinoma. If you have a spot that might be non-melanoma skin cancer or a pre-cancer, and your doctor already plans to scan and biopsy it, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a skin spot that your doctor thinks might be a type of skin cancer that is not melanoma, or a pre-cancerous spot.
- Your doctor has already decided to take a close-up scan (D-OCT) and a tiny skin sample (biopsy) of that spot as part of your normal care.
- You can understand and sign a consent form to be part of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new imaging technology that helps surgeons see if all the cancer cells have been removed during Mohs surgery for basal cell carcinoma. It may help improve accuracy and reduce the need for additional surgeries.
This study tests a new imaging tool called LC-OCT to see if it helps doctors remove all skin cancer during Mohs surgery. It might reduce the need for extra surgeries by giving clearer pictures in real time.
This trial is testing a special light-based technique (Raman spectroscopy) to see if it can help doctors better identify skin cancers. It is for people with either basal cell or squamous cell carcinoma who are scheduled to receive brachytherapy treatment.
This trial is testing a new microscope technique that may help doctors see more clearly whether all cancer cells have been removed during standard skin cancer surgery. It could help make sure the surgery is successful the first time.
This study tests a high-resolution scan (called OCT) to better see skin tumors before they’re removed or biopsied. It may help doctors evaluate both non-pigmented and pigmented skin spots that look like possible skin cancer.
This study looks at how well a new skin imaging tool (LC-OCT) works in everyday care for people being treated for skin cancer at Mohs clinics in the Netherlands. If you had this test and have follow-up information, your data could help doctors understand how useful the test really is.
Hear when a new Basal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.